Clinical Specialties Compounding Pharmacy Recalls Test Cyp 10 mg/ml Due to Sterility Concerns
Clinical Specialties Compounding Pharmacy is recalling Test Cyp 10 mg/ml vials due to FDA inspection findings regarding quality control and lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric, particularly given the risk of sterility failure in a compounded drug.
Plain-English summary
Clinical Specialties Compounding Pharmacy is recalling specific vials of Test Cyp 10 mg/ml. The recall is being conducted because FDA inspection findings resulted in concerns regarding the company's quality control processes and a lack of assurance of sterility.
The affected product is Test Cyp 10 mg/ml, 7ml vials, with lot number CABCAFBC:17 and an expiration date of 6/3/2013. The product was distributed in Florida, Georgia, and South Carolina.
Consumers and healthcare providers should stop using the affected product and contact the recalling firm or their healthcare provider for instructions on how to return or dispose of the medication.
The recalled product
- Product
- Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
- Manufacturer
- Clinical Specialties Compounding Pharmacy
- Category
- Drug — Compounded Medication
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot number CABCAFBC:17
- Exp date: 6/3/2013.
Distribution
Part of a larger recall action
This product is one of 49 recalled by Clinical Specialties Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Clinical Specialties Compounding Pharmacy
See all →- SevereAvastin Syringes Recalled for Sterility Concerns and Eye Infection Reports
FDA (Drugs) · 2013-09-04
- SevereClinical Specialties Compounding Pharmacy Recalls Test Cyp 250 mg-lidocaine 5 mg/ml
FDA (Drugs) · 2013-07-10
- SevereEstradiol Cypionate Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereClinical Specialties Compounding Pharmacy Recalls Test Cyp 200 mg/ml Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereClinical Specialties Compounding Pharmacy Recalls Test Cyp 100 mg/ml Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereRed Mountain Compounding Pharmacy Recalls S-TEST CYP Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereCustomceutical Compounding Recalls Test PROCYP Injectable Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereRed Mountain Compounding Recalls S-TEST CYP Vials Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereNatures Pharmacy Recalls Cyano B-12 Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- HighRed Mountain Compounding Pharmacy Recalls S-TEST CYP Vials for Sterility Concerns
FDA (Drugs) · 2019-11-13
- Severe